Friday, January 27, 2012

Ashkenazi Jewish women with BRCA1 mutations more likely to have TNBC

We know that women with triple-negative breast cancer are more likely to be young and premenopausal and that African-American Women are disproportionately affected by the disease. Now, a study in the Journal of Clinical Oncology adds another group that might be at special risk of TNBC: Ashkenazi Jewish women.

The details:

Ashkenazi Jewish women with BRCA1 mutations were five times more likely to be diagnosed with TNBC that were women from other ethnic and religious groups.

• The BRCA1 mutations in Ashkenazi Jewish women in the study had a specific genetic profile, as opposed to the genetic variations found in women from other groups.

• Researchers studied 1,469 patients from Los Angeles County between t20 and 49 years who had been diagnosed with and treated for breast cancer.

• The number of Ashkenazi Jewish women with the BRCA1 mutation were too small—13—for this study to be definitive, but it does raise an interesting question that deserves additional study.

No comments: